301 related articles for article (PubMed ID: 31774495)
21. Rapid Molecular Profiling of Myeloproliferative Neoplasms Using Targeted Exon Resequencing of 86 Genes Involved in JAK-STAT Signaling and Epigenetic Regulation.
Magor GW; Tallack MR; Klose NM; Taylor D; Korbie D; Mollee P; Trau M; Perkins AC
J Mol Diagn; 2016 Sep; 18(5):707-718. PubMed ID: 27449473
[TBL] [Abstract][Full Text] [Related]
22. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.
Chan MP; Plouffe KR; Liu CJ; Palanisamy N; Carskadon S; Zhao L; Nazarian RM; Durham AB; Johnson TM; Andea AA; Patel RM; Lowe L; Fullen DR; Brown NA; Tomlins SA; Udager AM; Harms PW
Mod Pathol; 2020 Jun; 33(6):1092-1103. PubMed ID: 31857679
[TBL] [Abstract][Full Text] [Related]
23. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.
Blombery P; Thompson ER; Jones K; Arnau GM; Lade S; Markham JF; Li J; Deva A; Johnstone RW; Khot A; Prince HM; Westerman D
Haematologica; 2016 Sep; 101(9):e387-90. PubMed ID: 27198716
[No Abstract] [Full Text] [Related]
24. RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes.
Di Napoli A; Vacca D; Bertolazzi G; Lopez G; Piane M; Germani A; Rogges E; Pepe G; Santanelli Di Pompeo F; Salgarello M; Jobanputra V; Hsiao S; Wrzeszczynski KO; Berti E; Bhagat G
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944796
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.
Ferrufino-Schmidt MC; Medeiros LJ; Liu H; Clemens MW; Hunt KK; Laurent C; Lofts J; Amin MB; Ming Chai S; Morine A; Di Napoli A; Dogan A; Parkash V; Bhagat G; Tritz D; Quesada AE; Pina-Oviedo S; Hu Q; Garcia-Gomez FJ; Jose Borrero J; Horna P; Thakral B; Narbaitz M; Hughes RC; Yang LJ; Fromm JR; Wu D; Zhang D; Sohani AR; Hunt J; Vadlamani IU; Morgan EA; Ferry JA; Szigeti R; C Tardio J; Granados R; Dertinger S; Offner FA; Pircher A; Hosry J; Young KH; Miranda RN
Am J Surg Pathol; 2018 Mar; 42(3):293-305. PubMed ID: 29194092
[TBL] [Abstract][Full Text] [Related]
26. Breast Implant-Associated Anaplastic Large Cell Lymphoma (ALCL): A Case Report.
Evren S; Khoury T; Neppalli V; Cappuccino H; Hernandez-Ilizaliturri FJ; Kumar P
Am J Case Rep; 2017 May; 18():605-610. PubMed ID: 28559535
[TBL] [Abstract][Full Text] [Related]
27. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
28. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
29. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
30. Analysis of JAK-STAT signaling pathway genes and their microRNAs in the intestinal mucosa of genetically disparate chicken lines induced with necrotic enteritis.
Truong AD; Rengaraj D; Hong Y; Hoang CT; Hong YH; Lillehoj HS
Vet Immunol Immunopathol; 2017 May; 187():1-9. PubMed ID: 28494922
[TBL] [Abstract][Full Text] [Related]
31. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Crescenzo R; Abate F; Lasorsa E; Tabbo' F; Gaudiano M; Chiesa N; Di Giacomo F; Spaccarotella E; Barbarossa L; Ercole E; Todaro M; Boi M; Acquaviva A; Ficarra E; Novero D; Rinaldi A; Tousseyn T; Rosenwald A; Kenner L; Cerroni L; Tzankov A; Ponzoni M; Paulli M; Weisenburger D; Chan WC; Iqbal J; Piris MA; Zamo' A; Ciardullo C; Rossi D; Gaidano G; Pileri S; Tiacci E; Falini B; Shultz LD; Mevellec L; Vialard JE; Piva R; Bertoni F; Rabadan R; Inghirami G;
Cancer Cell; 2015 Apr; 27(4):516-32. PubMed ID: 25873174
[TBL] [Abstract][Full Text] [Related]
32. Identification of the JAK-STAT pathway in canine splenic hemangiosarcoma, thyroid carcinoma, mast cell tumor, and anal sac adenocarcinoma.
Cletzer E; Klahn S; Dervisis N; LeRoith T
Vet Immunol Immunopathol; 2020 Feb; 220():109996. PubMed ID: 31958674
[TBL] [Abstract][Full Text] [Related]
33. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
[TBL] [Abstract][Full Text] [Related]
35. Recurrent chromosomal rearrangements of
Bayard Q; Caruso S; Couchy G; Rebouissou S; Bioulac Sage P; Balabaud C; Paradis V; Sturm N; de Muret A; Guettier C; Bonsang B; Copie C; Letouzé E; Calderaro J; Imbeaud S; Nault JC; Zucman-Rossi J
Gut; 2020 Sep; 69(9):1667-1676. PubMed ID: 31907296
[TBL] [Abstract][Full Text] [Related]
36. Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma.
Blombery P; Thompson E; Ryland GL; Joyce R; Byrne DJ; Khoo C; Lade S; Hertzberg M; Hapgood G; Marlton P; Deva A; Lindeman G; Fox S; Westerman D; Prince M
Oncotarget; 2018 Nov; 9(90):36126-36136. PubMed ID: 30546832
[TBL] [Abstract][Full Text] [Related]
37. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
[TBL] [Abstract][Full Text] [Related]
38. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
Kaartinen I; Sunela K; Alanko J; Hukkinen K; Karjalainen-Lindsberg ML; Svarvar C
Eur J Surg Oncol; 2017 Aug; 43(8):1385-1392. PubMed ID: 28625797
[TBL] [Abstract][Full Text] [Related]
39. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O; Kankainen M; Kelkka T; Sekiguchi N; Awad SA; Eldfors S; Yadav B; Kuusanmäki H; Malani D; Andersson EI; Pietarinen P; Saikko L; Kovanen PE; Ojala T; Lee DA; Loughran TP; Nakazawa H; Suzumiya J; Suzuki R; Ko YH; Kim WS; Chuang SS; Aittokallio T; Chan WC; Ohshima K; Ishida F; Mustjoki S
Nat Commun; 2018 Apr; 9(1):1567. PubMed ID: 29674644
[TBL] [Abstract][Full Text] [Related]
40. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
